期刊文献+

二次经尿道膀胱肿瘤电切治疗非浸润性膀胱肿瘤 被引量:5

Re-transurethral resection treatment for invasion bladder tumor
下载PDF
导出
摘要 目的:探讨非浸润性膀胱肿瘤的有效治疗方法。方法:回顾性分析经尿道膀胱肿瘤电切术+二次经尿道膀胱肿瘤电切术(TURBt+R-TURBt)治疗膀胱肿瘤73例和行膀胱部分切除术(开放手术组)治疗膀胱肿瘤67例的临床资料,将各指标进行统计学处理。结果:TURBt+R-TURBt组的手术时间、术中出血量、术后并发症等均明显小于开放手术组。结论:TURBt+R-TURBt治疗非浸润性膀胱肿瘤,具有操作简单、可重复多次操作、手术损伤小、术后恢复快、疗效确切等优点,值得临床推广应用。 Objective: To investigate a better treatment of the no invasion bladde tumor.Methods: 140 cases of non-invasive bladder tumor patients were treated by TURBT + R-TURBT(73 cases) and treated by partial cystectomy(67 cases).All the data were analyzed statistically.Results: The operation time,blood loss,postoperative complications,postoperative recurrence rate of TURBT + R-TURBT group were less than surgery partial cystectomy group.Conclusion: TURBT + R-TURBT have such advantages as simple surgical manipulation,less trauma,faster recovery,repeatedly performable process and safety.It is an ideal therapy for treating no invasion bladder tumor.
出处 《东南大学学报(医学版)》 CAS 2010年第6期665-667,共3页 Journal of Southeast University(Medical Science Edition)
关键词 非浸润性膀胱肿瘤 二次经尿道膀胱肿瘤电切术 膀胱部分切除术 non-invasion bladder tumor re-transurethral resection of bladder tumor partial cystectomy
  • 相关文献

参考文献11

二级参考文献73

  • 1李鸣,李宁忱,黄真,那彦群.浸润性膀胱癌术前选择性髂内动脉灌注化疗的近远期疗效观察[J].中华泌尿外科杂志,2004,25(10):662-664. 被引量:20
  • 2DASCHNER P J, CIOLINO H P, PLOUZEK C A, et al. Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells [ J]. Breast Cancer Res Treat, 1999,53 : 229-240.
  • 3ENOKIDA H, GOTANDA T, OKU S, et al, Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line [ J]. Jpn J Cancer Res, 2002, 93: 1037-1046.
  • 4LAMM D L.Prophylaxis for recurrent transitional cell carcinoma[J].Urology,1991,37(Suppl 5):21-23.
  • 5CHANG S Y,YU D S,WANG J,et al.Histopathological effects and recovery rate of rat bladders following intravesical instillation of thiotepa,doxorubiin and mitomycin C[J].Br J Urol,1990,66(6):623-627.
  • 6YAMAN L S,YURDAKUL T,ZISSIS N P,et al.Intravesical mitoxantrone for superficial bladder tumors[J].Anticancer Drugs,1994,5(1):95-98.
  • 7RICHIE J P.Intravesical chemotherapy.Treatment selection,techniques,and results[J].Urol Clin North Am,1992,19(3):521-527.
  • 8NAKAGAWA S,KOJIMA M,TAKADA H,et al.Short-duration bladder instillation therapy with pirarubicin for superficial bladder tumor based on pharmacodynamic study[J].Gan To Kagaku Ryoho,1992,19(11):1873-1877.
  • 9KOBAYASHI M,SUGAYA Y,YUZAWA M,et al.Appropriate intravesical retention time of pirarubicin concentration based on its level in tumor tissue,antitumor effect and side effect in intravesical instillation therapy for bladder tumor[J].Gan To Kagaku Ryoho,1998,25(11):1771-1774.
  • 10Mohr DN, Offord KP, Owen RA,et al. Asymptomatic microhematuria and urologic disease: a population -based study. JAMA, 1986, 256: 224 - 229.

共引文献62

同被引文献44

  • 1张逸仲,杨楚香,曾斌,李光昭,林建群,陈斌.实时三维彩色超声成像技术诊断膀胱癌28例[J].中国医学影像技术,2009,25(S1):117-119. 被引量:4
  • 2应文群,李巧星.hTERT和survivin在膀胱移行细胞癌中的表达及意义[J].肿瘤基础与临床,2006,19(1):19-20. 被引量:1
  • 3Yang Y, Wei ZT, Zhang X, et al. Transurethral partial cystectomy with continuous wave laser for bladder carcinoma [ J ] . J Urol, 2009, 182 ( 1 ) : 66-69.
  • 4Gupta A, Lotan Y, Bastian PJ, et al. Outcomes of patients with clinical T! grade 3 urothelial cell bladder carcinoma treated with radical cystectomy [ J ] . Urology, 2008, 71 ( 2 ) : 302-307.
  • 5Kulkarni GS, Finelli A, Fleshner NE, et al. Optimal management of high-risk T1G3 bladder cancer : a decision analysis [ J ] . PLoS Med, 2007, 4 ( 9 ) : e284.
  • 6Herr HW, Reuter VE. Progression of Tl bladder tumors : better staging or better biology? [ J ]. Cancer, 1999, 86 ( 6 ) : 905-912.
  • 7Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer : epidemiology, staging and grading, and diagnosis [ J ] . Urology, 2005, 66 ( 6 Suppl 1 ) : 4-34.
  • 8Brausi M, Collette L, Kurth K, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder : a combined analysis of seven EORTC studies [J] - Eur Urol, 2002, 41 ( 5 ) : 523-531.
  • 9Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors [J] . J Urol, 1999, 162 ( 1 ) : 74-76.
  • 10Soloway MS, Lee CT, Steinberg GD, et al. Difficult decisions in urologic oncology : management of high-grade T1 transitional cell carcinoma of the bladder [ J ] . Urol Oncol, 2007, 25 ( 4 ) : 338- 340.

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部